PTCB PTCE Exam Dumps

TheNational Institute for Occupational Safety and Health (NIOSH)publishes a list ofhazardous drugsthat require pharmacy staff to wear appropriatepersonal protective equipment (PPE)when handling.Megestrol (Megace) and Dutasteride (Avodart)are both classified as hazardous drugs due to their potentialteratogenic and reproductive toxicity risks.

Megestrolis aprogestinused for appetite stimulation in cancer and HIV patients. It poses arisk to pregnant healthcare workersdue to potential hormonal effects.

Dutasterideis a5-alpha reductase inhibitorused forbenign prostatic hyperplasia (BPH). It can beabsorbed through the skinand iscontraindicated in women of childbearing potentialdue to the risk offetal abnormalities.

Wear gloveswhen handling uncoated tablets or broken tablets.

Use respiratory protectionif there is a risk of airborne particles.

B . Furosemide and buspirone Incorrect; these arenot classified as hazardous drugsby NIOSH.

C . Glyburide and acetazolamide Incorrect; these arenot hazardous drugsrequiring PPE.

D . Glipizide and zolpidem Incorrect; these medications arenot hazardousper NIOSH guidelines.

NIOSH PPE Recommendations:Other Answer Choices Explained:Reference:

NIOSH List of Hazardous Drugs in Healthcare Settings (2020 Update)

USP <800> Hazardous Drug Handling in Healthcare Settings

PTCB PTCE Exam Content Outline (Medication Safety and Hazardous Drug Handling)

USP <800> mandates that hazardous drug exposure requires immediate decontamination.

Flushing the affected area with large amounts of water for at least 15minutes is the first step.

For eye exposure, an eye wash station must be used immediately.

Why Other Options Are Incorrect:

A . Writing a report first?Incident reports should be done AFTER flushing the area.

B . Ice bag?Ice can worsen chemical burns.

C . Soapy water?Soap may react with chemicals, causing further irritation.

Reference:USP <800> Hazardous Drug Handling, OSHA Chemical Safety Guidelines.

Cefdinir is a third-generation cephalosporin antibiotic commonly used to treat bacterial infections, including otitis media (middle ear infection) in children. It is available in both capsule and suspension forms. However, cefdinir suspension is supplied in different concentrations, typically125 mg/5 mLand250 mg/5 mL.

The prescription provided specifies'Cefdinir suspension 5 mL PO q12h x 10 days', but it does not mention the concentration (strength) of the suspension. Without this crucial information, the pharmacy cannot accurately determine the total dosage the patient will receive. Different strengths would result in significantly different amounts of cefdinir per dose.

For example:

If the prescriber intended125 mg/5 mL, then the patient would receive125 mg per dose (250 mg daily).

If the prescriber intended250 mg/5 mL, then the patient would receive250 mg per dose (500 mg daily).

This discrepancy could lead tounderdosing or overdosing, making it essential for the pharmacy to contact the prescriber to confirm the correct concentration before dispensing.

A . Cefdinir is not available as a suspension. Incorrect. Cefdinir is available inoral suspensionform, typically in 125 mg/5 mL and 250 mg/5 mL concentrations.

C . Cefdinir suspension is not indicated for otitis media. Incorrect. Cefdinir is FDA-approved for the treatment of otitis media in pediatric patients.

D . Cefdinir suspension was prescribed for a child old enough to swallow capsules. Incorrect. While some 8-year-old children may be able to swallow capsules, many pediatric patients prefer liquid formulations, and prescribers often choose suspensions for better compliance.

PTCB PTCE Exam Content Outline -- Medication Order Entry and Fill Process(Ensuring accuracy of prescriptions, including strength and formulation).

FDA Drug Label for Cefdinir-- Indicates available strengths and dosing requirements.

Lexicomp Drug Information for Cefdinir-- Lists the recommended pediatric dosages and available suspension concentrations.

Pharmacology Textbooks (e.g., 'Mosby's Pharmacy Technician: Principles and Practice')-- Reinforce the importance of verifying missing prescription details before dispensing.

Why the Other Answer Choices Are Incorrect:Pharmacy Technician Reference:

Comprehensive and Detailed Step-by-Step Explanation:

Desvenlafaxine (Pristiq)is anSNRI (Serotonin-Norepinephrine Reuptake Inhibitor)used to treatmajor depressive disorder (MDD).

Explanation of Answer Choices:B. Major depressive disorderCorrect.Desvenlafaxine is FDA-approved fordepression.A. Hypertension Incorrect.Not an antihypertensive.C. Benign prostatic hypertrophy Incorrect.Alpha-blockers like Tamsulosin treat BPH.D. Atrial fibrillation Incorrect.Beta-blockers, not SNRIs, manage atrial fibrillation.

Reference:

FDA Drug Database: Desvenlafaxine

PTCB Exam: Pharmacology for Technicians

Apidra (insulin glulisine)is arapid-acting insulinthat must bestored between 36F and 46F (2C to 8C)in the refrigerator. If frozen,it is no longer usableand shouldnever be thawed or dispensed. The best course of action is toreturn it to the distributorto ensure medication integrity and patient safety.

A . Thawed and stored in a refrigerator Incorrect;frozen insulin loses its potencyand shouldnot be used.

B . Sent to the prescriber Incorrect; the prescriber does not handle medication storage or replacements.

C . Dispensed to a patient Incorrect;frozen insulin is ineffectiveand could harm the patient.

Other Answer Choices Explained:Reference:

FDA Insulin Storage and Handling Guidelines

USP <797> Sterile Preparations -- Storage Conditions

Manufacturer Storage Requirements for Apidra (Sanofi-Aventis)